ClearFlow Inc. was founded with the mission to develop innovative medical devices that address the issue of obstructed catheters, aiming to improve patient outcomes across various medical segments. The company's vision is to enhance the efficiency and reliability of catheter-based treatments, thereby reducing complications and improving recovery times. ClearFlow offers products such as PleuraFlow and ClearFix, which are designed to prevent and resolve catheter clogging in applications including urinary, gastrointestinal, and wound drainage catheters. Their market focus spans multiple medical fields, providing critical solutions for both acute and chronic care settings.

Notable affiliated individuals include key speakers like Marc Gillinov, MD, Jurij M. Kalisnik, MD, and Lenard Conradi, MD, who contribute to the company's educational initiatives. ClearFlow has achieved significant milestones, including the successful implementation of their devices in clinical settings and recognition in medical communities for their contributions to improving catheter management. Their impact is evident in the enhanced patient care and reduced complications associated with catheter use, positioning ClearFlow as a leading innovator in the medical device industry.